ABSTRACTS

The Scientific and Organising Committee encourages all researchers and practitioners to consider contributing to the programme by submitting abstracts for poster or platform presentation.

Further information may be found in the sections below. Please note that the Abstract Submission system will open in December 2019 and will remain open until February 2020.

GUIDELINES

  • Abstracts should be submitted via the online submission system. Abstracts submitted after the deadline and abstracts submitted by fax or e-mail will not be reviewed by the Scientific Committee.
  • Abstracts should be sent in English
  • Abstracts should not exceed 300 words. This limit excludes the title, information about authors and institutions.
  • Authors will be notified in writing in April 2020 as to whether or not their abstract has been accepted by the Abstract Review Committee. The decision of the committee is final and no correspondence will be entered into.
  • Once an abstract has been accepted, the presenting author must register for the congress for final acceptance. An abstract presenter may not register as a day delegate. Proof of registration for the congress must be submitted to naec@epilepsycongress.org to finalise acceptance of the abstract.
  • Instructions for both platform and poster presentations will be available on the congress website. Authors selected for oral presentations should use Microsoft PowerPoint only (PC Format).
  • All correspondence will be sent to the submitting author only. It is the responsibility of the submitting author to forward any relevant correspondence to the presenting author.
  • Each author is permitted to present once (not including invited lectures)
  • Abstract submitters should ensure that the version sent is the final one; changes will not be permitted once the deadline has passed.
  • Institution information should be provided for all authors. Please include institution, city and country, but exclude department, division, laboratory, etc.
  • Authors are required to submit the abstract under one of the congress abstract topics.
  • Abstracts should be structured in 4 sections as follows:

Purpose:            Indicate the objectives of the work being presented.

Method:             Describe study material or subjects (e.g. number and type of patients), intervention and evaluation procedures.

Results:              Summarize the main findings. Wherever possible, give numerical values and statistical significance or confidence intervals.

Conclusion:        State briefly the conclusions reached in the work.

  • Figures, tables and other illustrations cannot be included.
  • If the work was supported by funds provided by a commercial organization this should be stated in a short acknowledgment at the end of the abstract. Other sources of funding may be acknowledged in the same way.
  • Multiple submissions of abstracts describing different components of the same study are not appropriate. All findings generated from the same study should be included in a single abstract.
  • Abstracts containing single case reports will not usually be accepted, unless the report is of outstanding scientific or clinical interest because of the uniqueness of the findings or the sophistication of the investigations.
  • Abstracts containing data considered to be insufficiently informative will not be accepted.
  • Authors should use a concise title that indicates the content of the abstract. Abbreviations should be avoided in the title.
  • For intervention studies (for example, therapeutic trials), the type of design (prospective or retrospective, controlled or uncontrolled, randomized or observational, open vs. single-blind vs. double-blind), dosages, assessment methods and duration of follow-up should be specified.
  • Non-proprietary names of drugs must be used throughout. If results are considered to be specific for a given proprietary product (for example, bio-equivalence studies), the non-proprietary name must still be used, followed by the proprietary name and the name of the manufacturers in brackets.
  • Abbreviations should be used sparingly. For words that are abbreviated, use the whole term the first time, followed by the standard abbreviation in parenthesis.
  • References should be used sparingly. They should be included within the text in brackets. For journals, mention first author “et al” followed by the name of the journal as abbreviated in the Index Medicus, year, volume number and inclusive pages (i.e. Hardus P et al. Epilepsia 2001;42:262-267.). For book chapters, give first author “et al”, editor, title, publisher, city of publication, year and inclusive pages (i.e. Levy RH et al. In: Levy RH et al, Antiepileptic Drugs. Lippincott-Raven, 1996;13-30.).
  • Submission of an abstract automatically implies acknowledgment that the work described was conducted in accordance with current ethical standards and regulations in biomedical research. Failure to adhere to these standards will result in rejection of the abstract.

The abstract topics for the congress are:

  1. Adult epileptology
  2. Basic sciences
  3. Classification and terminology
  4. Clinical neurophysiology
  5. Comorbidities
  6. Drug therapy
  7. Epidemiology
  8. Epilepsy in resource-restricted settings
  9. Epilepsy in special populations (gender aspects, pregnancy, intellectual disability, elderly)
  10. Epilepsy surgery
  11. Genetics
  12. Neuroimaging
  13. Neuropsychology & psychiatry of epilepsy
  14. Neurostimulation and devices
  15. Organisation of care and social issues
  16. Paediatric epileptology
  17. Status Epilepticus
  18. Other

ABSTRACT SUBMISSION

  • Can I make changes to my abstract after submission?

You can make any changes you wish to the abstract even if the abstract has been submitted, but the changes must be made before the abstract submission deadline. Once the abstract submission deadline has passed, changes are not permitted unless they relate to the results of the study; in this case only, please contact naec@epilepsycongress.org.

  • Can I submit an abstract after the deadline?

Late abstracts will not be accepted.

  • May an Encore Abstract be submitted?

Yes an Encore Abstract may be submitted providing that there is no copyright issue with the original publisher.

ABSTRACT ACCEPTANCE

  • When will I know if my abstract has been accepted?

Authors will be notified of the acceptance/ rejection of their abstract in April 2020.

  • How will I receive the information from the Congress Secretariat?

Contact details provided at the time of submission will be used for all correspondence related to the congress. Please ensure that the correct details are entered.

  • How will my abstract be presented at the congress?

Most abstracts are accepted for poster presentations, a few are selected for oral presentation. You will be informed of the format of your presentation at the time of acceptance notification.

  • My colleague has received confirmation of his acceptance and I did not, is there something wrong?

There may be a problem with your email address, therefore please contact naec@epilepsycongress.org